[8-K] PJT Partners Inc. Reports Material Event
PJT Partners Inc. filed an Item 5.07 Form 8-K disclosing the final results of its 18 June 2025 Annual Meeting of Stockholders. All three management-sponsored proposals received the necessary votes to pass.
Director elections: Paul J. Taubman was re-elected with 28,014,654 votes FOR (≈98.3%) and 494,070 WITHHOLD, while Emily K. Rafferty was re-elected with 23,326,315 votes FOR (≈81.8%) and 5,182,409 WITHHOLD. Broker non-votes totaled 4,065,896 for each nominee.
Say-on-Pay (advisory): Compensation of Named Executive Officers garnered strong support—32,697,067 FOR (≈97.8%), 731,896 AGAINST and 27,722 ABSTAIN, with 4,065,896 broker non-votes.
Auditor ratification: Deloitte & Touche LLP was ratified as independent auditor for 2025 with 36,786,380 FOR (≈98.1%), 701,910 AGAINST and 34,291 ABSTAIN.
No other matters were brought before shareholders, and the filing contains no financial performance data or strategic announcements.
- Strong shareholder support for Say-on-Pay (≈97.8% FOR), indicating investor confidence in executive compensation practices.
- Auditor ratification passed with ≈98.1% FOR votes, preserving continuity with Deloitte & Touche LLP and reducing audit-related risk.
- None.
Insights
TL;DR — Routine AGM; all proposals passed comfortably, limited investment impact.
The voting results indicate robust shareholder alignment with management. Say-on-Pay received nearly 98% support, exceeding typical S&P 500 averages (~92%), suggesting limited compensation-related dissent. Auditor ratification passed with an equally high margin, preserving continuity in financial oversight. Director re-election shows a divergence: Paul Taubman achieved near-unanimous backing, while Emily Rafferty’s 18% withhold rate signals moderate governance concerns but is still well within acceptable thresholds (<20-25% is generally considered manageable). Importantly, no proposals failed, and no new material actions (e.g., M&A, capital allocation changes) were introduced. As such, the disclosure is procedural; it does not alter valuation drivers, risk profile, or capital structure. I classify the filing as neutral/not impactful for investors.
